Stéphane Simon joins as VP, Chief Pharmaceutical Officer of IDD and CEO of Bio Valys Pharma. With 30 years of experience as a Qualified Person and a strong background in regulatory leadership, he will lead the development of a new strategic pillar focused on pharmaceutical commercialization.
Anne Walter takes on the role of Director of Pharmaceutical Affairs & Exploitation. With over three decades of experience in quality, pharmacovigilance, and compliance, she will strengthen IDD’s regulatory foundations and help shape its future strategic offerings.
Their appointments represent a significant milestone in IDD’s growth, reinforcing our expertise and expanding our capabilities for the years ahead.